Skip to main content
. 2019 Mar 1;10(18):1745–1755. doi: 10.18632/oncotarget.26741

Figure 5.

Figure 5

Kaplan-Meier plots showing (A) RFS for the 14 patients of cohort1, who received adjuvant treatment, dichotomized by the median cancer cell phospho-ERK score (6.0) (B) RFS for the 14 patients of cohort 1, dichotomized by the median stromal cell phospho-ERK score. (C) RFS for the 42 remaining patients of cohort 1, who did not receive adjuvant treatment (3 further patients of cohort1 lacked data regarding adjuvant treatment) dichotomized as in A. (D) RFS for the 17 patients of cohort 2, who fulfilled the criteria, but who did not receive, adjuvant treatment, dichotomized by the median cancer cell phospho-ERK score.